MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer
XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells . Proc Natl Acad Sci USA 2007; 104: 19983-8. 43. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities . Nat Med 2008; 14: 1271-7. 44. Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, et al. Regulatory Role of mir-203 in Prostate Cancer
Immunohistochemical Localization of Elastic System Fibres in the Canine Prostate
. Histol. Cytol. , 56, 441—449. 11. Murakumo, M., Ushiki, T., Abe, K., Matsumura, K., Shinno, Y., Koyanagi, T., 1995: Three dimensional arrangement of collagen and elastin fibres in the human urinary bladder: a scanning electron microscopic study. J. Urol. , 154, 251—256. 12. Sugimoto, K., Matsumoto, S., Uemura, H., Ito, H., 2008: Distribution of elastic fibers on prostate. Hinyokika kiyo. Acta Urol. Japonica , 54, 321—324. 13. Tuxhorn, J. A., Ayala, G. E., Rowley, D. R., 2001: Reactive stroma in prostate cancer progression. J. Urol. , 166, 2472
Influence of Membership Functions on Classification of Multi-Dimensional Data
: Class Discovery and Class Prediction by Gene Expression Monitoring," in Science. , Vol. 286, 1999, pp. 531-537. D Singh. et all, "Gene Expression Correlates of Clinical Prostate Cancer Behavior," Cancer Cell , Vol. 1, No. 2, March 2002, pp. 203-209. Broad Institute, "Broad institute home page" 2010. [Online]. Available: http://www.broadinstitute.org/cgi-bin/cancer/datasets.cgi
Technical report. Accuracy of intensity-modulated radiation therapy dose calculations: verification based on-board conebeam CT imaging
J, Sonke JJ, Betgen A, Zijp L, Jaffray DA, et al. Automatic prostate localization on cone-beam CT scans for high precision image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2005; 63: 975-84. 10. Mageras GS, Mechalakos. Planning in the IGRT context: closing the loop. Semin Radiat Oncol. 2007; 17:268-77. 11. Melancon AD, O’Daniel JC, Zhang L, Kudchadker RJ, Kuban DA, Lee AK, et al. Is a 3-mm intrafractional margin sufficient for daily image-guided intensitymodulated radiation therapy of prostate cancer? Radiather Oncol. 2007
Increased expression of SHP-1 is associated with local recurrence after radiotherapy in patients with nasopharyngeal carcinoma
’s of radiobiology revisited. Stem Cells 2010; 28: 639-48. 12. López-Ruiz P, Rodriguez-Ubreva J, Cariaga AE, Cortes MA, Colás B. SHP-1 in cell-cycle regulation. Anticancer Agents Med Chem 2011; 11: 89-98. 13. Rodriguez-Ubreva FJ, Cariaga-Martinez AE, Cortes MA, Romero-De Pablos M, Ropero S, López-Ruiz P, et al. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery. Oncogene 2010; 29: 345-55. 14. Tassidis H
Influence of epilobium angustifolium extract on 5α-reductase type 2 and mapk3 kinase gene expression in rats prostates
(1):15-8. 4. Von Löw EC, Perabo FG, Siener R, Müller SC. Review. Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data. In Vivo 2007; 21(2):189-204. 5. Dedhia RC, McVary KT. Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2008; 179(6):2119-25.PDR for Herbal Medicines. 4th ed. Thompson Healtcare Inc., USA 2007:903-4. 6. Van-Hellemont J. Compedium de Phytotherapie. Association Pharmaceutique, Brussels 1986. 7. Wichtl M. Herbal
The “question-mark” MR anatomy of the cervico-thoracic ganglia complex: can it help to avoid mistaking it for a malignant lesion on 68Ga-PSMA-11 PET/MR?
staging and follow-up of prostate cancer patients, turned out to gather also in sympathetic ganglia, including CTG/SG. 12 , 13 , 14 , 15 In such circumstances, the relatively small size of CTG/SG does not exclude them from suspicion of malignancy, when they show the radiotracer uptake on PET, because 68 Ga-PSMA ligand (PET/CT) has the functional potential do detect micrometastases even in non-enlarged, and therefore missed on only morphological CT assessment, lymph nodes. 16 , 17 Detection of uptake in CTG/SG on multimodal PET/CT imaging, causes the possibility
Metformin Impacts the Prognosis of Cancer Patients with Type 2 Diabetes
metformin associated with improved survival of diabetic prostate cancer patients. Ann Oncol 22: 2640-2645, 2011. 28. Spratt DE, Zhang C, Zumsteg ZS, Pei X, Zhang Z, Zelefsky MJ. Metformin and prostate cancer: Reduced development of castration-resistant disease and prostate cancer mortality. Eur Urol 63: 709-716, 2013. 29. Kaushik D, Karnes RJ, Eisenberg MS, Rangel LJ, Carlson RE, Bergstralh EJ. Effect of metformin on prostate cancer outcomes after radical prostatectomy. Urol Oncol 32: 43.e41-47, 2014. 30. Romero IL
Glycans as a Target in the Detection of Reproductive Tract Cancers
comparative study in human normal prostate, benign prostatic hyperplasia, and prostate cancer. Glycoconj J 1999; 16: 375-82. Chan FL, Choi HL, Ho SM. Analysis of glycoconjugate patterns of normal and hormone-induced dysplastic Noble rat prostates, and an androgen-independent Noble rat prostate tumor, by lectin histochemistry and blotting. Prostate 2001; 46 (1): 21-32. Abel PD, Foster CS, Tebbutt S, Williams G. Differences in expression of oligosaccharide determinants by phenotypically distinct sublines of the Dunning
Effect of Changing Phantom Thickness on Helical Radiotherapy Plan: Dosimetric Analysis
, Lock M, Harari PM, et al. Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy. Tech Cancer Res Treat. 2006;5:465-479. [20] Piotrowski T, Kaczmarek K, Bajon T, et al. Evaluation of Image-Guidance Strategies for Prostate Cancer. Technol Cancer Res Treat. 2014;13(6):583-591. [21] Yan D. Adaptive radiotherapy: merging principle into clinical practice. Semin Radiat Oncol. 2010;20(2):79-83. [22] Thörnqvist S, Hysing LB, Tuomikoski L, et al. Adaptive radiotherapy strategies for pelvic
